Get the Stockscreener App
0.5207
6.58%
-0.0367
After Hours:
.51
-0.0107
-2.05%
Mangoceuticals Inc stock is traded at $0.5207, with a volume of 466.96K.
It is down -6.58% in the last 24 hours and up +45.04% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$0.5574
Open:
$0.55
24h Volume:
466.96K
Relative Volume:
0.44
Market Cap:
$8.94M
Revenue:
$414.60K
Net Income/Loss:
$-19.21M
P/E Ratio:
-0.3213
EPS:
-1.6207
Net Cash Flow:
$-4.89M
1W Performance:
+26.44%
1M Performance:
+45.04%
6M Performance:
+1.64%
1Y Performance:
-70.25%
1-Day Range:
$0.51
$0.569
1-Week Range:
$0.4101
$0.57
52-Week Range:
$0.162
$2.75
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.5207 | 8.94M | 414.60K | -19.21M | -4.89M | -1.6207 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Mangoceuticals Inc Stock (MGRX) Latest News
TradingKey - TradingKey
MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey
Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey
Mangoceuticals, Inc. Revenue Breakdown – NASDAQ:MGRX - TradingView
Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mangoceuticals stock doubles after Texas lawsuit - MSN
MGRX Q3 2025 Earnings: Net Loss Widens as Pre-Revenue Biotech Focuses on Clinical PipelineEarnings Outlook Update - DonanımHaber
Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX - TradingView
Mangoceuticals (MGRX) Slips 2.46% as Stock Approaches Key Support at $0.34Time Weighted Price - dars.gov.et
Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
ETFs Investing in Mangoceuticals, Inc. Stocks - TradingView
Mangoceuticals (MGRX) Surges 10% as Stock Bounces from Key Support LevelGEX Level - dars.gov.et
Mangoceuticals, Inc. Subscription Agreement: Accredited Investor Requirements & SEC Compliance Explained - Minichart
Mangoceuticals Raises Capital via Private Equity Placement - TipRanks
Mangoceuticals (MGRX) completes $272,000 private placement of common shares - Stock Titan
Mangoceuticals Inc. (MGRX) Faces Continued Pressure, Testing Key Support Near $0.34Strangle Setup - dars.gov.et
Mangoceuticals, Inc. announced that it has received $0.272 million in funding - marketscreener.com
Mangoceuticals Inc (MGRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mangoceuticals (MGRX) Rallies 3.46% as Buyers Defend $0.34 SupportChannel Projection - dars.gov.et
Mangoceuticals Inc (MGRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market - Moomoo
MGRX Q3 2025 Earnings: Widening Losses and No Revenue as Mangoceuticals Navigates Pre‑Commercial Phase - dars.gov.et
MGRX Q3 2025 Earnings: EPS Loss of $0.69; Stock Declines 4.61% Amid Limited DataFinancial Data - DonanımHaber
Mangoceuticals Inc (MGRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mangoceuticals Inc (MGRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MGRX Q3 2025 Earnings: Loss Per Share Pressures Stock as Revenue Remains UndisclosedPeak Earnings Alert - dars.gov.et
MGRX Q3 2025 Earnings: EPS Loss of -$0.69 Highlights Ongoing Operational ChallengesPerformance Review - newsline.com
MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MGRX Q3 2025 Earnings: Loss Reported, No Revenue Disclosed as Stock DeclinesLong-Term Guidance - dars.gov.et
MGRX Technical Analysis & Stock Price Forecast - Intellectia AI
Number of shareholders of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
MGRX Q3 2025 Earnings: EPS of -$0.69 Reflects Ongoing Investment; Shares Dip 2.56%Subscription Growth Report - The Legal Advocate
MGRX Q3 2025 Earnings: Narrowing Losses as Strategic Pivot Gains MomentumSaaS Earnings Trends - DonanımHaber
MGRXMangoceuticals Inc Stock Price and Quote - Finviz
MGRX Q3 2025 Earnings: EPS Surprises with -$0.69 Loss as Revenue Remains UndisclosedROA Comparison - The Legal Advocate
Mangoceuticals Inc. (MGRX) Holds Near $0.44 After Marginal Uptick — Support and Resistance TightenVolume Profile - Newser
MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary - TradingView
Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash - Stock Titan
MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding - TradingView
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Mangoceuticals Delays Quarterly Filing After Audit Review - TipRanks
[NT 10-Q] MANGOCEUTICALS, INC. SEC Filing - Stock Titan
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
MGRX (Mangoceuticals) Q3 loss widens, but stock rallies 7% on positive outlook.Rating Upgrade - Newser
Is Mangoceuticals (MGRX) stock near support |Real-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Mangoceuticals (MGRX) Stock: Market Structure (Buying Pressure) 2026-04-20Collaborative Trading Signals - Newser
Mangoceuticals (MGRX) Stock: Should You Take Exposure (Smart Money Exits) 2026-04-18Top Analyst Buy Signals - Xã Thanh Hà
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JOHNSTON EUGENE M | CFO |
Dec 09 '25 |
Sale |
1.20 |
5,000 |
5,975 |
123,333 |
| JOHNSTON EUGENE M | CFO |
Dec 05 '25 |
Sale |
1.13 |
10,000 |
11,280 |
128,333 |
1.99%
2.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):